Related Experiment Video
Updated: Sep 16, 2025

Computerized Dynamic Posturography for Postural Control Assessment in Patients with Intermittent Claudication
Published on: December 11, 2013
Vestibular Rehabilitation Using Dynamic Posturography: Functional Stability and Fall Risk Outcomes From a Randomized
Eytan A David1, Navid Shahnaz2, Isabel Wiseman3
1Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada.
Objective:
To compare computerized vestibular retraining therapy (CVRT) to a home exercise program (HEP) for the treatment of unilateral vestibular deficits.
Study Design:
Randomized, unblinded, interventional study with single crossover.
Setting:
This study was performed in a tertiary neurotology clinic.
Methods:
Individuals with a stable unilateral vestibular deficit present for greater than 6 months, confirmed with videonystagmography and vestibular evoked myogenic potential testing and scoring >30 on the dizziness handicap inventory, received either 12 twice-weekly sessions of CVRT or 6 weeks of HEP. Outcome measures were the limits of stability test with submeasures: reaction time; directional control; movement velocity; endpoint and maximum excursion; endpoint and maximum functional stability region.
Results:
CVRT (n = 18), but not HEP (n = 12), was associated with improvement in all measures and with fewer instances of loss of balance during testing. CVRT was superior to HEP for directional control (24.0; 95% CI 4.4-43.6; P = .01), movement velocity (1.5; 95% CI 0.6-2.3; P < .001), and endpoint excursion (21.1; 95% CI 4.8-37.4; P < .01). Improvements in directional control (23.0; 95% CI 1.1-45.0; P = .046) and movement velocity (1.3; 95% CI 0.4-2.2; P = .04) were greater for HEP/CVRT crossover than for HEP alone. There were no adverse effects of either treatment.
Conclusion:
CVRT improved postural stability in the limits of stability test. CVRT was associated with greater improvement than HEP in lean angle, accuracy, and speed of volitional leaning.
Trial Registration:
Clinicaltrials.gov NCT05115032 (https://clinicaltrials.gov/study/NCT05115032).

